Day: June 23, 2025

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”) is pleased to announce a second follow-on investment of $1.5M in portfolio company, GetTattle Inc. (dba “Tattle”), a global Customer Experience Improvement (“CXI”) software-as-a-service (“SaaS”) platform focused primarily on the restaurant and hospitality sector. This follow-on round brings Flow Capital’s total investment in Tattle to US$5.5 million, and reaffirms the Company’s strong conviction in Tattle’s team, market opportunity, and long-term trajectory. The additional capital infusion will support Tattle’s continued growth driven by the launch of its AI Coach features, and further expand its presence within core enterprise verticals. Alongside the recent financing, Tattle announced the appointment of Kevin Quinn to its...

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash   Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business   Simplifies Operating Structure and Enables Achievement of Adjusted EBITDA Break-Even    Cash & Cash Equivalents of At Least $550 Million Expected at Close to Fuel Inorganic Growth Strategy and Drive Long-Term Value Creation SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) — Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced the strategic sale of SomaLogic to Illumina, Inc. (NASDAQ: ILMN) (“Illumina”), including SomaScan® Assay Services, Authorized Sites and KREX™ for an upfront payment of $350 million in cash at closing and up to $75 million in...

New Hire Follows Multiple Customer MOU Announcements in May and June, Ensuring USAR will Remain on Track to Deliver Neo Magnets and Support Customers in 2026 STILLWATER, Okla., June 23, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the appointment of Ron Fogarty as Vice President of Sales. Mr. Fogarty will lead global sales efforts in support of the Company’s sintered neodymium (neo) magnet production facility in Stillwater, Oklahoma. Mr. Fogarty has over 35 years of sales, business development and organizational enhancement experience, and most recently served as Vice President of Sales for ABB, a global technology leader in electrification and automation. Fogarty will bring his expertise in driving sustainable growth, streamlining go-to-market operations, and aligning teams...

– Potential Best-In-Class Bispecific Antibody ATI-052 Targets Both Thymic Stromal Lymphopoietin (TSLP) and Interleukin-4 Receptor (IL-4R) – WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has initiated a placebo-controlled Phase 1a/1b program for ATI-052, the Company’s potential best-in-class investigational bispecific anti-TSLP/IL-4R antibody. The program will consist of a Phase 1a single and multiple ascending dose (SAD/MAD) portion in healthy volunteers, followed by an expected Phase 1b proof of concept portion. “This is an important milestone in the development of ATI-052, our uniquely potent bispecific anti-TSLP/IL-4R antibody,...

Dynamic leader will lead global talent strategies to drive growth and innovation CHICAGO, June 23, 2025 (GLOBE NEWSWIRE) — Alicia Zuiker has joined TransUnion (NYSE: TRU) as Executive Vice President, Chief Human Resources Officer (CHRO), effective June 23, 2025. Zuiker is an accomplished CHRO with deep experience leading global talent strategies across a range of relevant industries including financial services, digital enablement and technology. Her leadership has helped both mature and entrepreneurial companies achieve transformation and growth. In her new role at TransUnion, she will oversee TransUnion’s Human Resources and Communications functions, reporting to TransUnion President and CEO Chris Cartwright and serving on the executive leadership team. “We have bold aspirations for growth and innovation at TransUnion, and our...

NASHVILLE, Tenn., June 23, 2025 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or the “Company”) today announced changes to its Board of Directors (“Board”), immediately reducing the size from 12 to 7 members. This reduction is part of a thoughtful effort to better align the size of the Board with other companies in the REIT industry, while maintaining the Board’s commitment to operating with best practices of corporate governance. In support of these efforts, five directors, Nancy Agee, Ajay Gupta, James Kilroy, Peter Lyle, and Christann Vasquez voluntarily retired from the Board, effective June 18, 2025. The Board’s independent chairman, Thomas Bohjalian said, “I would like to thank the retiring directors for their service and contributions to the Company, as well as their support and professionalism...

— Sale of 12 Properties Generates Approximately $313 Million in Gross Proceeds — Portfolio Sale Completed; Accelerates Deleveraging Plan and Transforms GNL to Single-Tenant Net Lease REIT NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) — Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”) announced that it has completed the final phase of its multi-tenant portfolio sale to RCG Ventures, LLC on June 18, 2025, including 12 encumbered properties. This third phase generated approximately $313 million in gross proceeds1, bringing total gross proceeds from the portfolio sale to $1.8 billion2. GNL plans on using the incremental net proceeds from the third phase of the multi-tenant portfolio sale to further reduce leverage by paying down the outstanding balance on GNL’s Revolving Credit Facility. The multi-tenant portfolio sale simplifies...

        Company Announcement No 28/2025Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk23 June 2025  Dear Sirs Sydbank A/S share buyback programme: transactions in week 25On 26 February 2025 Sydbank A/S announced a share buyback programme of DKK 1,350m. The share buyback programme commenced on 3 March 2025 and will be completed by 31 January 2026. The purpose of the share buyback programme is to reduce the share capital of Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under...

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and...

 Company announcement no. 31 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 33 44 00 00 23 June 2025 Page 1 of 1 Danske Bank share buy-back programme: transactions in week 25 On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025. The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions on Nasdaq Copenhagen...